pCDCAR1 ErbB2 h(28FcεRIγ), T(CAR-T-2-L337-2G)
The vector of anti-ErbB2 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human ErbB2. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-ErbB2 antibody linked to a CD28 transmembrane domain/ endodomain and FcεRIγ signaling domains. And the vector product was designed as a medicament, in particular in the treatment of cancer and in adoptive, target-cell specific immunotherapy.
Targeting Cell Type
Discription of Signaling Cassetes
CD28 (Cluster of Differentiation 28) is one of the proteins expressed on T cells that provide co-stimulatorysignals required for T cell activation and survival. CD28 is the receptor for CD80 (B7.1) and CD86 (B7.2) proteins which are expressed on antigen-presenting cells(APC). CD28 modulates the primary TCR/CD3ζ signal in a different fashion than the late costimulatory elements OX40 and 4-1BB. CD28 enhances the expression of downstream regulators that impact on T-cell proliferation, death, differentiation, and effector functions. CAR+ T cells containing the CD28 endodomain showed strikingly enhanced sustained T cell activation, growth, survival. And CD28 results in a brightly expressed, stable receptor as the transmembrane domain. Including CD28 costimulatory domains in CARs led to enhanced anti-malignancy efficacy.
The high-affinity IgE receptor, also known as FcεRI, or Fc epsilon RI, is the high-affinity receptor for the Fc region of immunoglobulin E (IgE). FcεRI is a key molecule involved in allergic reactions. It is a tetramer composed of 1alpha, 1 beta, and 2 gamma chains. The gamma chains are also subunits of other Fc receptors. The scFv-based CARs engineered to contain a signaling domain from FcεRIγ have been shown to deliver a potent signal for T cell activation and function.
erb-b2 receptor tyrosine kinase 2
ERBB2; erb-b2 receptor tyrosine kinase 2; NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu; receptor tyrosine-protein kinase erbB-2; herstatin; p185erbB2; proto-oncogene Neu; c-erb B2/neu protein; proto-oncogene c-ErbB-2; metastatic lymph node gene 19 protein; human epidermal growth factor receptor 2; neuro/glioblastoma derived oncogene homolog; tyrosine kinase-type cell surface receptor HER2; neuroblastoma/glioblastoma derived oncogene homolog; v-erb-b2 avian erythroblastic leukemia viral oncoprotein 2; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog; CD28; Chimeric antigen receptor; T cell; Retrovirus; CARs; Lentivirus; chimeric T cell receptors; chimeric immunoreceptors; chimeric antigen receptors; scFv; OTI5C4
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
||Lenti-HER2 CAR (scFv-CD28-41BB-CD3ζ, 6D) Viral Particle
||Lenti-ErbB2 CAR (scFv-CD28-FcεRIγ, OTI5C4) Viral Particle
||Human anti-Her2 T cell receptor (G8), pCDTCR1
||Murinized anti-HER2 T cell receptor (HER2-2), pCDTCR1
||Lenti-HER2 CAR (scFv-CD28-41BB-CD3ζ, 7G) Viral Particle
||Lenti-Her2 T cell receptor (E1) Viral Particle
||Human anti-HER2 T cell receptor, pCDTCR1
||Human anti-Her2 T cell receptor (H3), pCDTCR1
||Lenti-HER2 (TYLPTNASL) T cell receptor Viral Particle
||Human anti-Her2 T cell receptor (H5), pCDTCR1
||Lenti-Her2 T cell receptor (B10) Viral Particle
||Human anti-Her2 T cell receptor (G3), pCDTCR1
||Anti-HER2 VHH h(CD3ζ) CAR, [T]
||Anti-ErbB2 (L96) h(CD28-CD3ζ) CAR, pCDCAR1
||Anti-ErbB2 scFv h(CD4-CD3ζ) CART, pCDCAR1
||Anti-ErbB2 scFv h(CD28) CARNK, pCDCAR1
||Lenti-ErbB2 CAR (scFv-CD3ζ, OTI5C4) Viral Particle
||Anti-ErbB2 (C6.5) h(CD28-CD3ζ) CAR, pCDCAR1
||Anti-HER2 VHH h(CD28-41BB-CD3ζ) CAR, [T]
||Lenti-HER2 CAR (scFv-CD28-41BB-CD3ζ) Viral Particle